- Home
- BANR vs CNTA Comparison
BANR vs CNTA Comparison
Compare BANR & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BANR
- CNTA
- Stock Information
- Founded
- BANR 1890
- CNTA 2020
- Country
- BANR United States
- CNTA United Kingdom
- Employees
- BANR 1935
- CNTA N/A
- Industry
- BANR Major Banks
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- BANR Finance
- CNTA Health Care
- Exchange
- BANR Nasdaq
- CNTA Nasdaq
- Market Cap
- BANR 2.2B
- CNTA 1.6B
- IPO Year
- BANR 1995
- CNTA 2021
- Fundamental
- Price
- BANR $68.67
- CNTA $14.07
- Analyst Decision
- BANR Buy
- CNTA Strong Buy
- Analyst Count
- BANR 6
- CNTA 10
- Target Price
- BANR $70.40
- CNTA $28.78
- AVG Volume (30 Days)
- BANR 206.8K
- CNTA 1.2M
- Earning Date
- BANR 07-16-2025
- CNTA 08-12-2025
- Dividend Yield
- BANR 2.80%
- CNTA N/A
- EPS Growth
- BANR 5.82
- CNTA N/A
- EPS
- BANR 5.09
- CNTA N/A
- Revenue
- BANR $614,045,000.00
- CNTA $15,000,000.00
- Revenue This Year
- BANR $3.72
- CNTA N/A
- Revenue Next Year
- BANR $5.38
- CNTA N/A
- P/E Ratio
- BANR $13.49
- CNTA N/A
- Revenue Growth
- BANR 3.98
- CNTA 118.88
- 52 Week Low
- BANR $47.20
- CNTA $8.46
- 52 Week High
- BANR $78.05
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- BANR 73.11
- CNTA 60.47
- Support Level
- BANR $63.37
- CNTA $12.74
- Resistance Level
- BANR $64.66
- CNTA $14.27
- Average True Range (ATR)
- BANR 2.00
- CNTA 0.66
- MACD
- BANR 0.67
- CNTA 0.12
- Stochastic Oscillator
- BANR 97.51
- CNTA 85.57
About BANR Banner Corporation
Banner Corp is a bank holding company. It wholly owns one subsidiary bank, Banner Bank. The Bank's primary business is that of traditional banking institutions, accepting deposits and originating loans in locations surrounding its offices in Washington, Oregon, California, Idaho and Utah. Banner Bank also actively participates in the secondary loan markets, engaging in mortgage banking operations largely through the origination and sale of one to four family residential loans.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.